| Tag | Content |
|---|
EnhancerAtlas ID | HS187-09576 |
Organism | Homo sapiens |
Tissue/cell | Th1 |
Coordinate | chr16:67051640-67052440 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| CTCF | MA0139.1 | chr16:67051915-67051934 | ACACCTCCAGGGGGCACCA | + | 6.21 | | NFYA | MA0060.3 | chr16:67052049-67052060 | TCTGATTGGTT | - | 6.62 | | Nr2f6(var.2) | MA0728.1 | chr16:67052392-67052407 | GAGGTCAGGAGTTCA | + | 6.22 |
|
| | Number of super-enhancer constituents: 5 | ID | Coordinate | Tissue/cell |
| SE_05303 | chr16:67050859-67052283 | Brain_Cingulate_Gyrus | | SE_06173 | chr16:67049790-67052507 | Brain_Hippocampus_Middle | | SE_08271 | chr16:67050544-67052376 | Brain_Inferior_Temporal_Lobe | | SE_68619 | chr16:67046690-67067535 | TC71 | | SE_68620 | chr16:67046690-67067535 | TC71 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH16I067017 | chr16 | 67051703 | 67052304 |
|
Enhancer Sequence | TCTCAGACAC TCAACTGGCT TCTCTGATAC TCCCTGCCAG GAGAAATCCT AACCTGCCTG 60
GCCTCTAGGC GACCAATATA TCCACAATAC TCAGTATATC TGAGACAAGA ATATTTTTCT 120
GAAGAGTGAG GATGCAACTA TACCCAAACA ATCATTGGTA GTGGGAGGTC TCACGTGAGA 180
AGCAGGGAGG CAGCCTGAAT GTTGAACCCA TTATTCTGGT AGCAGCCCCA CCTGCCAGCA 240
TCCAGGTATG GCCGACAGAA TAGCTGTTGC AGCACACACC TCCAGGGGGC ACCATTTCCA 300
TGGTTTACAG TCTGAATGAG GCCTGAATGT AACCTGAGCT TCATGACTGC CTCCTCTGGG 360
CTTGGTACCC ACAGGCACAC TCACACTACA CACGTGCCTC AGAGAATGCT CTGATTGGTT 420
GATCACGATC ACCACCTAAC CTAAAGCATC CACATTGGTC AGGCTTTGGA GCCCGCACTT 480
CTGCTCTAGC TATGCATGGC TCCCTTCAGC TCCCAGGGCA GGTCCAGTCC CAGGTCCAGC 540
CAGATGATTT AGTGCTGATA GAAGCAGGAT CTTTTGAAAG AGCTATGGAT GTAGCAGGCC 600
CCAGAGGCTC AGGAAGTCCT TTCCAGGCCA TGCCCTGGTT CTGGCACTGC TACTGCCCCT 660
GCTCCACTAC TAAAGGAGGC AGGCCAGGCC ATGCATGGTG GCTCACGCCT GTAATTCCAG 720
CACTTTGGGA GGCCAAGGTG GGCAGATCTC CTGAGGTCAG GAGTTCAAGA CTAGCCTGGC 780
CAACATGGTG AAACCCCGTC 800
|
